Showing results (51-60 of 69) with videos related to

Sort By:
Pageof 7
BMC Psychiatry|June 1, 2013
Positive association between the plasma levels of 5-hydroxyindoleacetic acid and the severity of depression in patients with chronic obstructive pulmonary diseaseTomomi Sekiduka-Kumano, Tomotaka Kawayama, Kosuke Ito, et al.
Molecular and Cellular Biology|May 31, 2018
The Interaction between the Ribosomal Stalk Proteins and Translation Initiation Factor 5B Promotes Translation InitiationRyo Murakami, Chingakham Ranjit Singh, Jacob Morris, et al.
International Journal of Chronic Obstructive Pulmonary Disease|December 26, 2018
Characteristics of 2017 GOLD COPD group A: a multicenter cross-sectional CAP study in JapanKeiji Oishi, Tsunahiko Hirano, Kazuki Hamada, et al.
The Journal of Biological Chemistry|March 25, 2005
Recombinant porcine zona pellucida glycoproteins expressed in Sf9 cells bind to bovine sperm but not to porcine spermNaoto Yonezawa, Katsuyasu Kudo, Hirotomo Terauchi, et al.
European Journal of Radiology|September 27, 2022
Myelin-weighted imaging derived from quantitative parameter mappingYuki Kanazawa, Masafumi Harada, Yo Taniguchi, et al.
Magnetic Resonance Imaging|July 6, 2024
Three-dimensional simultaneous T1 and T2* relaxation times and quantitative susceptibility mapping at 3 T: A multicenter validation studyShohei Fujita, Akifumi Hagiwara, Koichiro Kimura, et al.
Biochemistry|August 17, 2019
Structural and Mutagenesis Studies Evince the Role of the Extended Protuberant Domain of Ribosomal Protein uL10 in Protein TranslationKwok-Ho Andrew Choi, Lei Yang, Ka-Ming Lee, et al.
Nucleic Acids Research|May 11, 2022
The flexible N-terminal motif of uL11 unique to eukaryotic ribosomes interacts with P-complex and facilitates protein translationLei Yang, Ka-Ming Lee, Conny Wing-Heng Yu, et al.
Nucleic Acids Research|July 30, 2013
Solution structure of human P1•P2 heterodimer provides insights into the role of eukaryotic stalk in recruiting the ribosome-inactivating protein trichosanthin to the ribosomeKa-Ming Lee, Kazuyuki Yusa, Lai-On Chu, et al.
Nucleic Acid Therapeutics|January 20, 2021
Considerations of the Japanese Research Working Group for the ICH S6 & Related Issues Regarding Nonclinical Safety Assessments of Oligonucleotide Therapeutics: Comparison with Those of BiopharmaceuticalsYoko Hirabayashi, Kazushige Maki, Kiyoshi Kinoshita, et al.
Pageof 7